Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TWIK-related potassium channel 1 (TREK-1) is a member of the two-pore-domain potassium (K2P) channel family. It is a potassium leak channel that produces instantaneous and non-inactivating K+ currents. TREK-1 is mechanosensitive and responds to temperature changes, pH shifts, fatty acids, and certain anesthetics. It plays a role in regulating neuronal excitability, pain perception, mood regulation, and cardiovascular function. Inhibition of TREK-1 has been linked to antidepressant-like effects. Dysregulation may contribute to arrhythmias such as atrial fibrillation.
Potassium channel blocker
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TWIK-related potassium channel 1 (TREK-1).